Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

70.1K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.1K
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

61.6K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
61.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Single Treatment of Mature 3D Single-, Dual- and Poly-Species Biofilms Using a Combination Therapy of Phage or Phage-Hetero-Cocktails and Ciprofloxacin.

Antibiotics (Basel, Switzerland)·2026
Same author

Towards a reference methodology for bacteriophage susceptibility testing - position paper of the EUCAST Phage Susceptibility Testing Subcommittee.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

DepoCatalog: mapping diversity of 129 recombinantly produced Klebsiella phage depolymerases.

Nature communications·2026
Same author

Assetizing Diversity: Microbial Culture Collections in an Age of Biotechnology, Biodiversity, and Speculative Value Generation (1972-2022).

Journal of the history of biology·2026
Same author

Culture, Codes, Communities: Culture Collections' Transformation from Microbial Palaces to Networked Services (1890-1972).

Journal of the history of biology·2026
Same author

Pyrogenicity of phage active pharmaceutical ingredients used for personalized therapy in Belgium.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2026

相关实验视频

Updated: May 21, 2025

Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics
09:23

Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics

Published on: January 5, 2024

1.7K

解决现代菌体治疗中的研究和开发缺口

Paul E Turner1,2,3, Joana Azeredo4,5, Ed T Buurman6

  • 1Department of Ecology and Evolutionary Biology, Yale University, New Haven, Connecticut, USA.

PHAGE (New Rochelle, N.Y.)
|March 21, 2025
PubMed
概括

菌体治疗是一种有前途的方法,可以对抗抗微生物药物耐药性的上升. 本综述探讨了菌体研发方面的挑战和创新,旨在为细菌感染提供可访问的治疗方法.

关键词:
抗微生物耐药性 抗微生物耐药性生物膜是一种生物膜.生物技术是生物技术.患者可以访问.个性化医疗是个性化的医疗.

更多相关视频

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
07:22

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

Published on: August 19, 2021

2.7K
Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice
08:46

Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice

Published on: January 26, 2024

1.4K

相关实验视频

Last Updated: May 21, 2025

Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics
09:23

Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics

Published on: January 5, 2024

1.7K
Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
07:22

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

Published on: August 19, 2021

2.7K
Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice
08:46

Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice

Published on: January 26, 2024

1.4K

科学领域:

  • 微生物学 微生物学
  • 生物技术是生物技术.
  • 传染性疾病 传染性疾病

背景情况:

  • 全球抗菌素耐药性增加需要新的治疗策略.
  • 菌体 (菌体) 疗法为治疗细菌感染提供了传统抗生素的可行替代方案.
  • 显著的挑战阻碍了菌体治疗的广泛研发和临床应用.

研究的目的:

  • 审查目前的菌体治疗研究和开发的现状.
  • 识别和讨论菌体研发中的关键操作,认识和生物挑战.
  • 探索新兴技术和方法,包括人工智能和合成生物学,以推进菌体治疗.

主要方法:

  • 对菌体治疗研究的综合文献综述.
  • 在抗微生物药物发现的背景下对研发挑战和机遇的分析.
  • 讨论基于菌体的治疗方法的商业化和可访问性模型.

主要成果:

  • 菌体研发面临标准化,监管途径和理解菌体与细菌相互作用的障碍.
  • 人工智能和合成生物学为菌体发现,工程和生产提供了潜在的解决方案.
  • 目前的抗微生物创新模式对菌体疗法开发和进入市场存在局限性.

结论:

  • 克服研发挑战对于实现菌体治疗的全部潜力至关重要.
  • 需要创新的方法来确保全球平等地获得基于菌体的治疗方法.
  • 探索替代资金和生产模式对于可持续的菌体疗法开发至关重要.